Lot Release Certificate View

Lot Release Number 2020-02-11-0031
FDA Registered Product/Generic Name Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
Brand Name Hexaxim
Dosage Strength 0.5 mL
Dosage Form Suspension for Injection (I.M.)
Registration Number BR-919
Batch/Lot Number R3K57
Packaging Lot Packaging lot: R3K572V, MD: 26062018, ED: 05-2021, PFS: R3K57, MD: 26062018, ED: 05-2021; Needle 25G x 5/8": 1908002, ED: 2024-07-31; Needle 23Gx1": 1905050, ED: 2024-04-30 R3K573V, MD: 26062018, ED: 05-2021; PFS: R3K57, MD: 26062018, ED: 05-2021; Needle 25G x 5/8": 1908001, ED: 2024-07-31; Needle 23Gx1": 1905008, ED: 2024-04-30
Product Expiration Date 31 May 2021
Issuance Date 13 February 2020